Vuong Huy Gia, Altibi Ahmed M A, Abdelhamid Amr Hesham, Ngoc Phuong Uyen Duong, Quan Vo Duy, Tantawi Mohamed Yousef, Elfil Mohamed, Vu Tran Le Huy, Elgebaly Ahmed, Oishi Naoki, Nakazawa Tadao, Hirayama Kenji, Katoh Ryohei, Huy Nguyen Tien, Kondo Tetsuo
Department of Pathology, University of Yamanashi, Yamanashi, Japan.
Department of Pathology, Cho Ray Hospital, Ho Chi Minh City, Vietnam.
Oncotarget. 2017 Feb 7;8(6):10637-10649. doi: 10.18632/oncotarget.12885.
The genetic alterations of papillary thyroid carcinoma (PTC) have been reported to change over the past few decades. We performed this systematic review to further examine the trends and modifications of patient demographic, clinicopathological features and molecular profiles of PTC over time.
A literature search was performed within six electronic databases to identify relevant articles. The inclusion criteria were published studies investigating BRAF mutations, RET/PTC rearrangements or RAS mutations in PTCs or classical PTCs. Two teams of reviewers independently screened titles and abstracts of all articles. Full texts of potential articles were read and extracted data were listed and stratified into an excel file according to country, city, institution, and surgical time period. Student t test and Pearson Chi-square were used to analyze the trends of demographic and clinicopathological features of PTC patients and the prevalence of each genetic alteration in individual institutions.
From 3139 articles, we included 16 articles for final analysis. Our results showed an increasing trend of BRAF and a decreasing trend of RET/PTC prevalence over time in PTCs and classical PTCs, accompanied by an older age of PTC patients, an increase in proportion of PTMC and less aggressive behaviours of tumours.
The demographic and clinicopathological characteristics and molecular profile of PTCs have been changing over the past few decades. These modifications suggest changes in etiologies and risk factors of thyroid cancer that influence the tumorigenesis of PTCs.
据报道,过去几十年间甲状腺乳头状癌(PTC)的基因改变有所变化。我们进行了这项系统评价,以进一步研究PTC患者的人口统计学、临床病理特征和分子特征随时间的变化趋势及改变。
在六个电子数据库中进行文献检索,以识别相关文章。纳入标准为发表的研究PTC或经典PTC中BRAF突变、RET/PTC重排或RAS突变的研究。两组评审员独立筛选所有文章的标题和摘要。阅读潜在文章的全文,并将提取的数据根据国家、城市、机构和手术时间段列出并分层到一个Excel文件中。使用学生t检验和Pearson卡方检验分析PTC患者的人口统计学和临床病理特征趋势以及各基因改变在各个机构中的患病率。
从3139篇文章中,我们纳入了16篇文章进行最终分析。我们的结果显示,在PTC和经典PTC中,BRAF患病率呈上升趋势,RET/PTC患病率呈下降趋势,同时PTC患者年龄增大,PTMC比例增加,肿瘤侵袭性降低。
在过去几十年间,PTC的人口统计学、临床病理特征和分子特征一直在变化。这些改变提示甲状腺癌的病因和危险因素发生了变化,从而影响了PTC的肿瘤发生。